UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000001205
Receipt No. R000001470
Scientific Title Phase II study of weekly paclitaxel (wP) followed by doxorubicin plus paclitaxel (AP) as neo-adjuvant chemotherapy for triple negative Breast Cancer (WePAP)
Date of disclosure of the study information 2008/06/21
Last modified on 2018/12/18 19:53:20

No. Disposal Last modified on Item of update
1 Insert 2008/06/20 20:12:44
2 Update 2011/12/20 18:49:21 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2013/12/21 08:08:36 Email
4 Update 2015/02/16 19:07:10 Recruitment status
Last follow-up date
5 Update 2017/11/30 18:03:27 UMIN ID1
6 Update 2018/12/18 19:53:20 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Contact us.